These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 24054476)

  • 1. Stroke prevention in atrial fibrillation in heart failure.
    Shantsila E; Lip GY
    Heart Fail Clin; 2013 Oct; 9(4):427-35, viii. PubMed ID: 24054476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation in elderly patients with heart failure: convergence of two cardiovascular epidemics in the 21st Century.
    Svetlichnaya J; Klein L
    Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):903-12. PubMed ID: 21809972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in management of atrial fibrillation in patients with heart failure.
    Shantsila E; Lip GY
    Curr Opin Cardiol; 2013 Mar; 28(2):197-208. PubMed ID: 23385332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation in heart failure in the older population.
    Heck PM; Lee JM; Kistler PM
    Heart Fail Clin; 2013 Oct; 9(4):451-9, viii-ix. PubMed ID: 24054478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of atrial fibrillation on outcomes in heart failure.
    DePasquale EC; Fonarow GC
    Heart Fail Clin; 2013 Oct; 9(4):437-49, viii. PubMed ID: 24054477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into atrial fibrillation.
    Mischke K; Knackstedt C; Marx N; Vollmann D
    Minerva Med; 2013 Apr; 104(2):119-30. PubMed ID: 23514988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous monitoring of atrial fibrillation in heart failure.
    Herweg B; Barold SS; Steinberg JS
    Heart Fail Clin; 2013 Oct; 9(4):385-95, vii. PubMed ID: 24054472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation and quality of life related to disease and treatment: focus on anticoagulation.
    Ynsaurriaga FA; Peinado RP; Ormaetxe Merodio JM
    Future Cardiol; 2014 May; 10(3):381-93. PubMed ID: 24976475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation.
    Han J; Cheng J; Mathuria N
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):887-96. PubMed ID: 22452616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.
    Fernandez MM; von Schéele B; Hogue S; Kwong WJ
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for primary and secondary stroke prevention in atrial fibrillation.
    Finsterer J; Stöllberger C
    Neth J Med; 2008 Sep; 66(8):327-33. PubMed ID: 18809979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG; Albers GW
    J Am Coll Cardiol; 2004 Mar; 43(6):929-35. PubMed ID: 15028346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
    Skanes AC; Healey JS; Cairns JA; Dorian P; Gillis AM; McMurtry MS; Mitchell LB; Verma A; Nattel S;
    Can J Cardiol; 2012; 28(2):125-36. PubMed ID: 22433576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.
    Lip GY
    Thromb Haemost; 2010 Apr; 103(4):683-5. PubMed ID: 20135056
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke prevention in atrial fibrillation.
    Verheugt FW
    Neth J Med; 2006 Feb; 64(2):31-3. PubMed ID: 16517985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical atrial fibrillation: how hard should we look?
    Wachter R; Stahrenberg R; Gröschel K
    Heart; 2013 Feb; 99(3):151-3. PubMed ID: 23010289
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidenced-based pharmacotherapy for rate control in atrial fibrillation.
    Greenberg H
    Crit Care Nurs Q; 2013; 36(2):237-43. PubMed ID: 23470710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.